Primary sclerosing cholangitis is an idiopathic, heterogeneous, cholestatic liver disease that is characterized by persistent, progressive, biliary inflammation and fibrosis. There is no effective ...

Acute cholangitis is diagnosed on the basis of the clinical features, supported by laboratory evidence of systemic infection. Imaging is helpful in revealing biliary obstruction and any underlying ...

Cholangitis and cholecystitis are two conditions that share some similarities but have different causes and symptoms. Cholangitis affects the bile ducts, while cholecystitis affects the gallbladder.

PARIS — Statins can significantly reduce the risk for complications and death from primary sclerosing cholangitis, results from a Swedish registry study show. Primary sclerosing cholangitis is ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio In a Healio video exclusive, Andreas ...

FDA on Wednesday restricted the use of obeticholic acid (Ocaliva) in primary biliary cholangitis (PBC) due to the risk of serious liver injury in patients with advanced cirrhosis. Serious side effects ...

Patients who used proton pump inhibitors were at higher risk for developing cholangitis, according to study results. Juhee Cho, PhD, of the department of clinical research design and evaluation at ...

– New findings to be presented at the 2025 European Association for the Study of the Liver (EASL) Congress continue to demonstrate the effectiveness of Livdelzi (seladelpar) in reducing pruritus in ...

Primary sclerosing cholangitis (PSC) is a disease that affects your bile ducts. Bile is a digestive fluid your Liver makes. The ducts let it flow from your liver to your gallbladder and finally to ...